Krebs Biochemicals and Industries CEO, MD, chairman, board of directors and AGM
NSE: KREBSBIOBSE: 524518Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹57.48.
- Under NSE's long-term additional surveillance, stage I, on the list for 23 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Next results date: the board meets on 29 Oct 2026 to consider: financial results and other business matters.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹112 Cr2,740th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Net worth zero or below
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business.
- Net worth zero or below
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 6 Aug 2026
- −14.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- Net worth zero or below
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 27,82269.3% delivered
Krebs Biochemicals and Industries board of directors
At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- ChairpersonRAVI RAVINDRANATH TAGORERelated to the promoter
- Managing director and CEOMANISH KUMAR JAIN
- Company Secretary and Compliance OfficerRakesh R Kalbate
8 directors4 independent1 executive3 non-executive
- RAVI RAVINDRANATH TAGORE · ChairpersonNon-executive · joined Oct 1992 · reappointed Aug 2015 · 1 listed board
- AVINASH RAVINon-executive · joined Feb 2009 · reappointed Jul 2021 · 1 listed board
- PABITRAKUMAR KALIPADA BHATTACHARYYANon-executive · joined Jul 2021 · reappointed Aug 2023 · 2 listed boards · 2 committee seats
- MANISH KUMAR JAIN · Managing director and CEOExecutive · joined Aug 2025 · reappointed Aug 2025 · 1 listed board · 2 committee seats
- POPATLAL MUKANCHAND KATHARIYAIndependent · joined Feb 2025 · reappointed Feb 2025 · 20 months as independent · 1 listed board · 1 as independent · 2 committee seats, 1 as chair
- DIPTI CHINUBHAI SHAHIndependent · joined Feb 2025 · reappointed Feb 2025 · 20 months as independent · 2 listed boards · 2 as independent · 3 committee seats
- SATYA PRAKASH CHIGURUPATIIndependent · joined Feb 2025 · reappointed Feb 2025 · 20 months as independent · 1 listed board · 1 as independent · 2 committee seats
- SUMANTH KARLAPUDIIndependent · joined Feb 2025 · reappointed Feb 2025 · 20 months as independent · 1 listed board · 1 as independent · 2 committee seats, 1 as chair
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
5 directors who left
- JITENDRA RAMESHCHANDRA SHAH, left 7 Aug 2025: Others
- SATISH KHEMCHAND KHIVSARA, left 1 Apr 2025: Tenure Completion
- MALATI TANGIRALA, left 12 Mar 2025: Tenure Completion
- RAJ KAMAL PRASAD VERMA, left 13 Feb 2025: Tenure Completion
- VENKATA LAKSHMI PRASAD GUNDAPANENI, left 1 Jan 2025: Tenure Completion
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 6 Aug 20267 of 8 present3 independent · 40 days in between
- 26 Jun 20266 of 8 present3 independent · 35 days in between
- 21 May 20266 of 8 present3 independent
Audit Committee
Chair POPATLAL MUKANCHAND KATHARIYA
DIPTI CHINUBHAI SHAH, SATYA PRAKASH CHIGURUPATI, SUMANTH KARLAPUDI, MANISH KUMAR JAIN
- 6 Aug 20264 of 5 present3 independent · 40 days in between
- 26 Jun 20264 of 5 present3 independent · 35 days in between
- 21 May 20264 of 5 present3 independent
Nomination and remuneration committee
Chair SATYA PRAKASH CHIGURUPATI
SUMANTH KARLAPUDI, DIPTI CHINUBHAI SHAH, POPATLAL MUKANCHAND KATHARIYA
No meeting listed in the filing.
Stakeholders Relationship Committee
Chair SUMANTH KARLAPUDI
DIPTI CHINUBHAI SHAH, POPATLAL MUKANCHAND KATHARIYA, SATYA PRAKASH CHIGURUPATI, MANISH KUMAR JAIN
No meeting listed in the filing.
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- M/s. BHAVANI & COPeer-review certificate valid to Jul 2026
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Krebs Biochemicals and Industries AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Krebs Biochemicals and Industries share news and announcements
Annual general meeting, 29 Sep 2026
8,749 shareholders on the register on 23 Sep 2026; present: 3 promoters and 40 others; votes counted by Kritika Sharma / Kritika Sharma.The company's voting result (opens in a new tab)
To receive, consider, approve and adopt the Audited Balance Sheet, the Statement of Profit & Loss and Cash Flow Statement for the financial year ended 31st March 2026 together with the Notes attached thereto along with the Reports of Auditors and Directors thereon.MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 1.50%
Turnout: all 72.72% · promoters 99.87% · institutions 0.00% · other public 0.25%
- To appoint a director in place of Dr. R T Ravi (DIN - 00272977), who retires by rotation and being eligible, offers himself for re-appointment.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 1.52%
Turnout: all 72.70% · promoters 99.84% · institutions 0.00% · other public 0.25%
- To appoint a director in place of Mr. Manish Kumar Jain (DIN - 06477976), who retires by rotation and being eligible, offers himself for re-appointment.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 3.41%
Turnout: all 72.68% · promoters 99.87% · institutions 0.00% · other public 0.11%
- Approval for Related Party Transactions with Ipca Laboratories LimitedOrdinaryPromoters have an interest in it96.58% for3.42% against
Against: promoters 0.00% · institutions 0.00% · other public 3.42%
Turnout: all 0.03% · promoters 0.00% · institutions 0.00% · other public 0.11%
- To ratify the remuneration payable to the Cost AuditorsOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 1.53%
Turnout: all 72.72% · promoters 99.87% · institutions 0.00% · other public 0.25%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 26 Sep 2025, 9 resolutions
9,111 shareholders on the register on 19 Sep 2025; present: 6 promoters and 25 others; votes counted by Kritika Sharma / Kritika Sharma.The company's voting result (opens in a new tab)
To receive, consider, approve and adopt the Audited Balance Sheet, the Statement of Profit & Loss and Cash Flow Statement for the financial year ended 31st March 2025 together with the Notes attached thereto along with the Reports of Auditors and Directors thereon.MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 3.41%
Turnout: all 72.67% · promoters 99.87% · institutions 0.00% · other public 0.08%
- To appoint a director in place of Mr. Avinash Ravi (DIN- 01616152), who retires by rotation and being eligible, offers himself for re-appointment.OrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 3.41%
Turnout: all 60.17% · promoters 82.69% · institutions 0.00% · other public 0.08%
- To appoint a director in place of Mr. Pabitrakumar K Bhattacharyya (DIN- 07131152), who retires by rotation and being eligible, offers himself for re-appointment.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 3.41%
Turnout: all 72.67% · promoters 99.87% · institutions 0.00% · other public 0.08%
- To appoint Statutory Auditors and fix their remuneration.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 3.41%
Turnout: all 72.67% · promoters 99.87% · institutions 0.00% · other public 0.08%
- Appointment of Mr. Manish Kumar Jain (DIN: 06477976) as DirectorOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 3.41%
Turnout: all 72.67% · promoters 99.87% · institutions 0.00% · other public 0.08%
- Appointment of Mr. Manish Kumar Jain (DIN- 06477976) as Managing Director and CEO of the Company and consider remuneration payable to himSpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 3.41%
Turnout: all 72.67% · promoters 99.87% · institutions 0.00% · other public 0.08%
- Approval for Related Party Transactions with Ipca Laboratories LimitedOrdinaryPromoters have an interest in it95.43% for4.57% against
Against: promoters 0.00% · institutions 0.00% · other public 4.57%
Turnout: all 0.02% · promoters 0.00% · institutions 0.00% · other public 0.08%
- To ratify the remuneration payable to the Cost AuditorsOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 3.41%
Turnout: all 72.67% · promoters 99.87% · institutions 0.00% · other public 0.08%
- To appoint M/s. DSMR & Associates, Practicing Company Secretaries as the Secretarial Auditor of the Company for a period of 5 (five) consecutive years commencing from financial year 2025-26.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 3.41%
Turnout: all 72.67% · promoters 99.87% · institutions 0.00% · other public 0.08%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 28 Mar 2025, 4 resolutions
9,061 shareholders on the register on 21 Feb 2025; votes counted by Kritika Sharma / Kritika Sharma.The company's voting result (opens in a new tab)
- Appointment of Mr. Popatlal Mukanchand Kathariya (DIN: 00281395) as an Independent Director of the CompanySpecial99.92% for0.08% against
Against: promoters 0.00% · institutions 0.00% · other public 21.86%
Turnout: all 72.92% · promoters 99.87% · institutions 0.00% · other public 1.02%
- Appointment of Ms. Dipti Chinubhai Shah (DIN: 07995542) as an Independent Director of the CompanySpecial99.92% for0.08% against
Against: promoters 0.00% · institutions 0.00% · other public 21.86%
Turnout: all 72.92% · promoters 99.87% · institutions 0.00% · other public 1.02%
- Appointment of Mr. Satya Prakash Chigurupati (DIN: 00721318) as an Independent Director of the CompanySpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.26%
Turnout: all 72.92% · promoters 99.87% · institutions 0.00% · other public 1.03%
- Appointment of Mr. Sumanth Karlapudi (DIN: 09188185) as an Independent Director of the CompanySpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.26%
Turnout: all 72.92% · promoters 99.87% · institutions 0.00% · other public 1.03%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 27 Sep 2024, 7 resolutions
Present: 6 promoters and 30 others.The company's voting result (opens in a new tab)
To receive, consider, approve and adopt the Audited Balance Sheet, the Statement of Profit & Loss and Cash Flow Statement for the financial year ended 31st March 2024 together with the Notes attached thereto along with the Reports of Auditors and Directors thereonMoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.09%
Turnout: all 73.37% · promoters 99.87% · institutions 0.00% · other public 2.69%
- To appoint a director in place of Dr. R. T. Ravi (DIN: 00272977), who retires by rotation and being eligible, offers himself for reappointmentOrdinary99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.74%
Turnout: all 63.42% · promoters 86.20% · institutions 0.00% · other public 2.69%
- To appoint a director in place of Mr. P. K. Bhattacharya (DIN: 07131152), who retires by rotation and being eligible, offers himself for reappointmentOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.09%
Turnout: all 73.37% · promoters 99.87% · institutions 0.00% · other public 2.69%
- To appoint Auditors and fix their remunerationOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.09%
Turnout: all 73.37% · promoters 99.87% · institutions 0.00% · other public 2.69%
- Continuation of Dr. Malati Tangirala (DIN: 07094957) as a Non-Executive Independent Director of the Company after attaining the age of 75 yearsSpecial99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.74%
Turnout: all 73.37% · promoters 99.87% · institutions 0.00% · other public 2.69%
- Approval for Related Party Transactions with Ipca Laboratories LimitedOrdinaryPromoters have an interest in it99.26% for0.74% against
Against: promoters 0.00% · institutions 0.00% · other public 0.74%
Turnout: all 0.72% · promoters 0.00% · institutions 0.00% · other public 2.69%
- To ratify the remuneration of the Cost Auditors for the financialnyear ending March 31, 2025Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.09%
Turnout: all 73.37% · promoters 99.87% · institutions 0.00% · other public 2.69%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 27 Sep 2023, 7 resolutions
Present: 8 promoters and 26 others.The company's voting result (opens in a new tab)
To receive, consider, approve and adopt the Audited Balance Sheet, the Statement of Profit & Loss and Cash Flow Statement for the financial year ended March 31, 2023 together with the Notes attached thereto along with the Reports of Auditors and Directors thereon.MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.09%
Turnout: all 74.08% · promoters 99.93% · institutions 0.00% · other public 5.19%
- To appoint a director in place of Mr. Jitendra Shah (holding DIN- 09377846), who retires by rotation and being eligible, offers himself for re-appointment.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.14%
Turnout: all 74.08% · promoters 99.93% · institutions 0.00% · other public 5.19%
- To appoint a director in place of Mr. Avinash Ravi (holding DIN- 01616152), who retires by rotation and being eligible, offers himself for re-appointment.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.14%
Turnout: all 74.08% · promoters 99.93% · institutions 0.00% · other public 5.19%
- Appointment of Mr. Jitendra Shah (DIN- 09377846) as Managing Director / CEO of the CompanySpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.12%
Turnout: all 74.08% · promoters 99.93% · institutions 0.00% · other public 5.19%
- Continuation of Dr. R T Ravi (DIN- 00272977) as a Non-Executive Director of the CompanySpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.12%
Turnout: all 74.08% · promoters 99.93% · institutions 0.00% · other public 5.19%
- Approval for Related Party Transactions with Ipca Laboratories LimitedOrdinaryPromoters have an interest in it99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.09%
Turnout: all 24.43% · promoters 31.67% · institutions 0.00% · other public 5.19%
- To ratify the remuneration of the Cost Auditors for the financial year ending March 31, 2024Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.09%
Turnout: all 74.08% · promoters 99.93% · institutions 0.00% · other public 5.19%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 17 Mar 2023, 1 resolution
The company's voting result (opens in a new tab)
- To maintain the books of accounts and the statutory registers of the Company at the registered officeSpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 73.57% · promoters 99.94% · institutions 0.00% · other public 3.27%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 30 Sep 2022, 6 resolutions
Present: 14 promoters and 29 others.The company's voting result (opens in a new tab)
- Approval of financial statements for the year ended 31.03.2022Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.04%
Turnout: all 75.54% · promoters 100.00% · institutions 0.00% · other public 10.27%
- To appoint a director in place of Dr. R T Ravi (DIN-00272977), who retires by rotation and being eligible, offers himself for re-appointment.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.04%
Turnout: all 75.54% · promoters 100.00% · institutions 0.00% · other public 10.27%
- To appoint a director in place of Mr. Avinash Ravi (DIN-01616152), who retires by rotation and being eligible, offers himself for re-appointment.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.04%
Turnout: all 75.54% · promoters 100.00% · institutions 0.00% · other public 10.27%
- To regularize the appointment of Mr. Jitendra Shah (DIN 09377846) as DirectorOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.04%
Turnout: all 75.54% · promoters 100.00% · institutions 0.00% · other public 10.27%
- To Approve Related Party Transactions with M/s. Ipca Laboratories Limited.Ordinary99.95% for0.05% against
Against: promoters 0.00% · institutions 0.00% · other public 0.05%
Turnout: all 2.14% · promoters 0.00% · institutions 0.00% · other public 7.84%
- Ratification of the remuneration payable to the cost Auditor for the Financial Year 2022-2023.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.04%
Turnout: all 75.54% · promoters 100.00% · institutions 0.00% · other public 10.27%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Extraordinary general meeting, 29 Nov 2021, 2 resolutions
Present: 12 promoters and 39 others.The company's voting result (opens in a new tab)
- INCREASE IN THE AUTHORIZED SHARE CAPITAL OF THE COMPANY AND CONSEQUENTIAL AMENDMENT OF THE CAPITAL CLAUSE IN THE MEMORANDUM OF ASSOCIATION OF THE COMPANYOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 73.84% · promoters 99.99% · institutions 0.00% · other public 4.07%
- ISSUE, OFFER AND ALLOT 9% REDEEMABLE NON-CONVERTIBLE NON-CUMULATIVE PREFERENCE SHARES, ON PRIVATE PLACEMENT BASIS.SpecialPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.04%
Turnout: all 24.19% · promoters 31.74% · institutions 0.00% · other public 4.07%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- No
- The chair is related to the managing director
- No
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- No
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.